Evidence map›Paper›PMID 31686534›Full record

ReviewCNS oncology2019

The role of chemotherapy in the treatment of central neurocytoma.

Margaret O Johnson, John P Kirkpatrick, Mallika P Patel, Annick Desjardins, Dina M Randazzo, Henry S Friedman, David M Ashley, Katherine B Peters

Open access · goldAbstract readReview
In one paragraph

Review in CNS oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Delving Inside the Enigmatic Central Neurocytoma: Electronic Hospital Database Retrieval.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Margaret O JohnsonDepartment of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.ORCID 0000-0003-1208-622X
John P KirkpatrickRadiation Oncology, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA.
Mallika P PatelDepartment of Pharmacy, Duke University Hospital, Durham, NC ;27710, USA.
Annick DesjardinsDepartment of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.
Dina M RandazzoDepartment of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.
Henry S FriedmanDepartment of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.
David M AshleyDepartment of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.
Katherine B PetersDepartment of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.
Duke University Hospital · USDuke Medical Center · USGTx (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsBrain NeoplasmsHumansNeurocytomaTreatment OutcomeAntineoplastic Agentsatypical neurocytomacentral neurocytomachemotherapydrug therapyneurocytomaradiosensitizertemozolomidetherapy

Identifiers

PMID31686534
PMCPMC6880304
OpenAlexW2988698437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.